NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018.


Journal Article

Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.

Full Text

Duke Authors

Cited Authors

  • Streiff, MB; Holmstrom, B; Angelini, D; Ashrani, A; Bockenstedt, PL; Chesney, C; Fanikos, J; Fenninger, RB; Fogerty, AE; Gao, S; Goldhaber, SZ; Gundabolu, K; Hendrie, P; Lee, AI; Lee, JT; Mann, J; McMahon, B; Millenson, MM; Morton, C; Ortel, TL; Ozair, S; Paschal, R; Shattil, S; Siddiqi, T; Smock, KJ; Soff, G; Wang, T-F; Williams, E; Zakarija, A; Hammond, L; Dwyer, MA; Engh, AM

Published Date

  • November 2018

Published In

Volume / Issue

  • 16 / 11

Start / End Page

  • 1289 - 1303

PubMed ID

  • 30442731

Pubmed Central ID

  • 30442731

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2018.0084


  • eng

Conference Location

  • United States